Reported about 10 hours ago
On February 12, the S&P 500 fell 0.3% amidst higher-than-expected inflation data, while CVS Health's shares soared 14.9% after it exceeded quarterly profit estimates, buoyed by growth in its pharmacy and consumer wellness segments. Other notable movers included Wabtec, which dropped 9.1% after disappointing results, and Gilead Sciences, which rose 7.5% on better-than-expected earnings.
Source: YAHOO